Overdose antidote availability doesn’t always mean fewer deaths, study says

For the new study, Doleac and her co-author, Anita Mukherjee, an assistant professor at the Wisconsin School of Business at the University of Wisconsin-Madison, examined the effects of broadened access to the lifesaving drug across the United States.